Bepridil hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for bepridil hydrochloride and what is the scope of patent protection?

Bepridil hydrochloride is the generic ingredient in two branded drugs marketed by Medpointe Pharm Hlc and Johnson And Johnson, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for bepridil hydrochloride.

Summary for bepridil hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	2
NDAs:	2
Drug Master File Entries:	1
Raw Ingredient (Bulk) Api Vendors:	60
Clinical Trials:	2
DailyMed Link:	bepridil hydrochloride at DailyMed

Recent Clinical Trials for bepridil hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Turin, Italy	Phase 1
University of Liverpool	Phase 1
St Stephens Aids Trust	Phase 1

See all bepridil hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for bepridil hydrochloride

Anti-Arrhythmia Agents
Antihypertensive Agents
Calcium Channel Blockers
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for bepridil hydrochloride

C08EA	Phenylalkylamine derivatives
C08E	NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C08	CALCIUM CHANNEL BLOCKERS
C	Cardiovascular system

US Patents and Regulatory Information for bepridil hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-002	Dec 28, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-003	Dec 28, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-003	Dec 28, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for bepridil hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-001	Dec 28, 1990	⤷ Sign Up	⤷ Sign Up
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-001	Dec 28, 1990	⤷ Sign Up	⤷ Sign Up
Medpointe Pharm Hlc	BEPADIN	bepridil hydrochloride	TABLET;ORAL	019001-003	Dec 28, 1990	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.